7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Middleton K et al. | Microfluidic co-culture platform for investigating osteocyte-osteoclast signalling during fluid shear stress mechanostimulation. | 2017 | J Biomech | pmid:28552413 |
| Jung YJ et al. | Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. | 2017 | Mol Oral Microbiol | pmid:27484636 |
| Lu LY et al. | Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. | 2017 | J. Orthop. Res. | pmid:28248001 |
| Kuroyanagi G et al. | (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. | 2017 | Prostaglandins Other Lipid Mediat. | pmid:28163121 |
| Liu XY et al. | Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway. | 2017 | Int. Immunopharmacol. | pmid:28092862 |
| Choi EM et al. | Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. | 2017 | Environ. Toxicol. | pmid:28836330 |
| Chen X et al. | Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation. | 2017 | Environ. Toxicol. Pharmacol. | pmid:28738286 |
| Ozaki Y et al. | Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. | 2017 | PLoS ONE | pmid:28937990 |
| Tschiderer L et al. | Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. | 2017 | PLoS ONE | pmid:28837646 |
| Åšliwicka E et al. | Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. | 2017 | PLoS ONE | pmid:28732027 |
| Bergdolt S et al. | Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. | 2017 | PLoS ONE | pmid:28614388 |
| Spirlandeli AL et al. | Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. | 2017 | Clinics (Sao Paulo) | pmid:28492723 |
| Liu J et al. | MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. | 2017 | PLoS ONE | pmid:28319142 |
| Songia P et al. | Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. | 2017 | Oxid Med Cell Longev | pmid:28261377 |
| Jia J et al. | Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. | 2017 | Mol Med Rep | pmid:28260003 |
| Shetelig C et al. | Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. | 2017 | PLoS ONE | pmid:28253327 |
| Irtyuga O et al. | NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. | 2017 | Biomed Res Int | pmid:28246602 |
| Hanmoto T et al. | Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. | 2017 | Biomed. Res. | pmid:28239034 |
| Fioramonti M et al. | Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. | 2017 | Oncotarget | pmid:28223547 |
| Xiong L et al. | Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. | 2017 | J. Cell Biol. | pmid:28193701 |
| Fortner RT et al. | Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. | 2017 | BMC Med | pmid:28173834 |
| Chung ST et al. | Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. | 2017 | Mol. Cancer | pmid:28143606 |
| Yin LL et al. | Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. | 2017 | Eur Rev Med Pharmacol Sci | pmid:28121359 |
| Bondar C et al. | Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. | 2017 | Int J Mol Sci | pmid:28098793 |
| Shu R et al. | Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. | 2017 | PLoS ONE | pmid:28081119 |
| Ji J et al. | Pathway of 3-MCPD-induced apoptosis in human embryonic kidney cells. | 2017 | J Toxicol Sci | pmid:28070108 |
| Sponder M et al. | Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. | 2017 | BMC Cardiovasc Disord | pmid:28056805 |
| Hygum K et al. | MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. | 2017 | Eur. J. Endocrinol. | pmid:28049653 |
| Dawson S and Lawrie A | From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. | 2017 | Pharmacol. Ther. | pmid:27373854 |
| Yu M et al. | Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. | 2016 Apr-Jun | J Cancer Res Ther | pmid:27461682 |
| Dela Cruz A et al. | Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27006198 |
| Lis GJ et al. | Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. | 2016 | Pol. Arch. Med. Wewn. | pmid:27003233 |
| Tsuruda T et al. | Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. | 2016 | Hypertension | pmid:27001297 |
| Kats A et al. | Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. | 2016 | J. Cell. Mol. Med. | pmid:26987561 |
| Moran CS et al. | Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. | 2016 | Arterioscler. Thromb. Vasc. Biol. | pmid:26966276 |
| Cong Q et al. | p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. | 2016 | Stem Cell Reports | pmid:26947973 |
| Li N et al. | Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. | 2016 | Pharmazie | pmid:29441931 |
| Yuan SY et al. | Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. | 2016 | Chin J Nat Med | pmid:27114313 |
| Li J et al. | Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. | 2016 | Mol Med Rep | pmid:26647856 |
| Cervellati C et al. | Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. | 2016 | Oxid Med Cell Longev | pmid:26635910 |
| Zhao N et al. | Isolation and Functional Analysis of an Immortalized Murine Cementocyte Cell Line, IDG-CM6. | 2016 | J. Bone Miner. Res. | pmid:26274352 |
| Liu YD et al. | Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. | 2016 | Osteoarthr. Cartil. | pmid:26256766 |
| Wang S et al. | Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. | 2016 | J Ethnopharmacol | pmid:27109342 |
| Bergamini A et al. | Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. | 2016 | Int J Med Sci | pmid:28090190 |
| Shirakawa J and Kulkarni RN | Novel factors modulating human β-cell proliferation. | 2016 | Diabetes Obes Metab | pmid:27615134 |
| Xing R et al. | Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. | 2016 | Int. J. Mol. Med. | pmid:27599586 |
| Yongdi L et al. | [Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. | 2016 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:27526445 |
| Qian H et al. | FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. | 2016 | Mol Med Rep | pmid:27510616 |
| Røysland R et al. | Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. | 2016 | PLoS ONE | pmid:27463973 |
| Piemontese M et al. | Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27460899 |